You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
An improved Bacillus subtilis cell factory for producing scyllo-inositol, a promising therapeutic agent for Alzheimer’s disease
|
---|---|
Published in |
Microbial Cell Factories, December 2013
|
DOI | 10.1186/1475-2859-12-124 |
Pubmed ID | |
Authors |
Kosei Tanaka, Shintaro Tajima, Shinji Takenaka, Ken-ichi Yoshida |
Abstract |
Bacillus subtilis 168 possesses an efficient pathway to metabolize some of the stereoisomers of inositol, including myo-inositol (MI) and scyllo-inositol (SI). Previously we reported a prototype of a B. subtilis cell factory with modified inositol metabolism that converts MI into SI in the culture medium. However, it wasted half of initial 1.0% (w/v) MI, and the conversion was limited to produce only 0.4% (w/v) SI. To achieve a more efficient SI production, we attempted additional modifications. |
Mendeley readers
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Indonesia | 1 | 3% |
India | 1 | 3% |
Unknown | 29 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 23% |
Student > Bachelor | 5 | 16% |
Researcher | 5 | 16% |
Student > Master | 4 | 13% |
Student > Doctoral Student | 2 | 6% |
Other | 4 | 13% |
Unknown | 4 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 8 | 26% |
Biochemistry, Genetics and Molecular Biology | 6 | 19% |
Medicine and Dentistry | 4 | 13% |
Nursing and Health Professions | 2 | 6% |
Engineering | 2 | 6% |
Other | 5 | 16% |
Unknown | 4 | 13% |